Home
Hua Medicine

Hua Medicine Market Share Analysis for June 2026

首页华领医药是一家立足中国，针对全球糖尿病患者尚未满足的临床需求，研发全球原创新药的生物技术公司。华领医药汇聚全球高端人才和科技资源，以国际顶级生物医药投资团队为依托，成功实现了全球首创糖尿病新药dorzagliatin（hms5552）在中国完成药品可开发性临床验证，率先进入注册性临床试验阶段。公司已在中国开展2个iii期临床试验，分别针对新发未经治疗的和二甲双胍治疗失效的2型糖尿病患者人群。公司将启动药品生命周期管理相关临床试验，并拓展糖尿病个性化治疗和管理的先进理念，联合中国和美国糖尿病领域专家，实现对糖尿病和代谢性疾病及其并发症的有效控制。

Industry: N/A

Domainhuamedicine.com

Year Founded2010

Employees51 - 200

Annual Revenue$2M - $5M

Hua Medicine

Hua Medicine (including company regionals)

huamedicine.com

See more website traffic and engagement information

Hua Medicine Revenue up to June 2026 is 2M - 5M

revenue generated by Hua Medicine top domains

Hua Medicine top domains revenue over 3 years

Revenue for Hua Medicine top domains

huamedicine.com2M - 5M

See more with Sales Intelligence

Total visits to Hua Medicine's top domains

Understand Hua Medicine market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

huamedicine.com2.2K

See more with Sales Intelligence

Avg. visit duration in Hua Medicine's top domains

Analyze Hua Medicine engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

huamedicine.com00:00:40

See more with Sales Intelligence

Avg. pageviews on Hua Medicine's top domains

See how Hua Medicine keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

huamedicine.com1.72

See more with Sales Intelligence

Hua Medicine top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Hua Medicine

These are the website technologies, by industry, used by Hua Medicine top domains

Payment & Currencies (21)

PayPal

Conversion & Analytics (3)

Clarity

Email Services (2)

G Suite

Advertising (1)

PubMatic

More Technologies

2

See all

News & Signals from Hua Medicine

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHua Medicine partnered with GemVCare Limited on Jul 6th '26.[NEWS] Hua Medicine enters research collaboration agreement with GemVCare to generate real-world evidence for dorzagliatin in Hong Kong.

NewsHua Medicine partnered with DKSH Management Ltd. on Jun 29th '26.The partnership brings together Hua Medicine's expertise in metabolic disease drug development and DKSH's integrated market expansion capabilities to deliver long-term value and meaningful healthcare impact across the region.

NewsHua Medicine is developing breakthrough technologies and products.Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care.